Modified recombinant human erythropoietin with potentially reduced immunogenicity. Susantad T, Fuangthong M, Tharakaraman K, Tit-Oon P, Ruchirawat M, Sasisekharan R. Sci Rep. 2021 Jan 15;11(1):1491.

15 Jan 2021
0

Modified recombinant human erythropoietin with potentially reduced immunogenicity.

Susantad T, Fuangthong M, Tharakaraman K, Tit-Oon P, Ruchirawat M, Sasisekharan R.

Sci Rep. 2021 Jan 15;11(1):1491.

Tags

Share this

Related Posts

Comparative proteomic analysis of lung cancer cell line and lung fibroblast cell line. Rubporn A, Srisomsap C, Subhasitanont P, Chokchaichamnankit D, Chiablaem K, Svasti J, Sangvanich P*. Cancer Genomics Proteomics. 2009 Jul-Aug;6(4):229-37.

Recent Posts